CELESTIAL — Celestial Biolabs Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesMicro Cap

Annual income statement for Celestial Biolabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2015 March 31st	2016 March 31st	2017 March 31st	R2018 March 31st	2019 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	Interim Report	PRESS
Standards:	IAS	IAS	IAS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	275	329	387	428	490
Cost of Revenue
Gross Profit	215	140	109	141	203
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	221	300	350	387	467
Operating Profit	53.8	28.5	36.9	41.3	23
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12.3	18.5	36.7	41.1	14
Provision for Income Taxes
Net Income After Taxes	13	20.8	33.3	33.3	-0.281
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	13	20.8	33.3	33.3	-0.281
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	13	20.8	33.3	33.3	-0.281
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.698	0.92	1.48	1.47	-0.012
Dividends per Share